Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient by John Yeakel, MD, Aarthi Kannan, BA, Nicole Hook Rattigan, PhD, Maki Yamamoto, MD, Alexey Aleshin, MD, MBA, Jeremy P. Harris, MPhil, MD, Ling Gao, MD, PhD

Connect to this object online.